Catheter Precision, Inc. (VTAK)
Oxford Ledge is still expanding full research coverage of VTAK. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
Catheter Precision designs and sells cardiac electrophysiology medical devices including imaging and mapping systems for arrhythmia treatment.
SEC filings
- S-1/A Amended registration statement 2026-07-06
- S-1 IPO / securities registration statement 2026-06-22
- 8-K Entry into material agreement; Financial statements and exhibits 2026-06-08
- 8-K Results of operations / financial condition; Financial statements and exhibits 2026-05-18
- 10-Q Quarterly financial report (unaudited) 2026-05-18
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for VTAK. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open VTAK in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.